Johnson & Johnson To Split In Two

One will operate its Consumer Health division and the other will focus on its Pharmaceutical and Medical Devices units.

The move will see the company separate its Consumer Health business into a new publicly-traded company, controlling brands such as Neutrogena, Aveeno, Tylenol, Listerine, Johnson’s, and Band-Aid.

The Consumer Health business is expected to generate revenue of approximately $15bn this year and, following the planned separation, the new company would generate sales in over 100 countries.

NamNews Implications:

• This move will endow each company with promotional flexibility
• …without compromising the other.
• Rivals need to anticipate even more focused initiatives from the separated companies.

#PostLockdownSplits #NewNorm